Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
B
Bioventus Inc
NASDAQ:BVS
Bioventus Inc
NASDAQ:BVS
Price:
14.53
USD
0.76%
Market Closed
Market Cap:
$984.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bioventus Inc
NASDAQ:BVS
|
US |
|
D
|
Drax Group PLC
F:D9F2
|
UK |
|
C
|
Coles Group Ltd
F:2OF
|
AU |
|
Tatton Asset Management PLC
F:2T7
|
UK |
Wall St Price Targets
BVS Price Forecast
Based on 6 analysts
Based on 6 analysts
+26% Upside
from
$14.53
today
Bioventus Inc (BVS)’s 12-month stock price forecast through October 2027 has a consensus target of $18.36, implying 26% upside. The forecast is based on price targets from 6 Wall Street analysts.
Bioventus Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BVS's stock price target?
Price Target
18.36
USD
18.36
USD
According to Wall Street analysts, the average 1-year price target for BVS is 18.36 USD with a low forecast of 15.15 USD and a high forecast of 19.95 USD.
What is the Revenue forecast for Bioventus Inc?
Projected CAGR
7%
7%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for Bioventus Inc?
Projected CAGR
8%
8%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for Bioventus Inc?
Projected CAGR
25%
25%
The compound annual growth rate for Operating Income over the next 3 years is 25%.
What is the Pre-Tax Income forecast for Bioventus Inc?
Projected CAGR
39%
39%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 39%.
What is the Net Income forecast for Bioventus Inc?
Projected CAGR
49%
49%
The compound annual growth rate for Net Income over the next 3 years is 49%.